Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using bioceramic materials to repair bone defects

Official title: Clinical Study of Bioceramic Materials in Bone Defect Repair

Run by Nanjing First Hospital, Nanjing Medical University · NCT06249906 · Data updated 2026-11-12

This study is testing if a new type of bioceramic implant can help people heal better from bone defects compared to a standard bone implant.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorNanjing First Hospital, Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedFebruary 20, 2024
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedMarch 12, 2024
Trial IDNCT06249906 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 with no history of allergies and who can communicate effectively with the research team.

Probably not a fit

Patients with severe cardiopulmonary diseases, cognitive impairments, or those with acute infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of bioceramic implants, specifically β-tricalcium phosphate, in repairing human bone defects. It will explore how the controlled microstructure of these implants can enhance bone regeneration, accelerate recovery, and improve overall bone quality. Participants will be divided into groups receiving either a commercial bone implant or a micro-structured bioceramic implant to assess the outcomes of each approach.

Why it matters

Potential benefit: If successful, this study could lead to improved healing and recovery for patients with various bone injuries and conditions.

How similar studies have gone: Other studies have shown promising results with bioceramic materials in bone repair, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients who voluntarily take the test and sign the informed consent form;
2. Patients aged 18-65 years old with no history of allergies;
3. Patients able to communicate well with the investigator and follow the requirements of the entire trial.

Exclusion Criteria:

1. Patients who refuse to sign the informed consent form to participate in the trial;
2. Patients who are not in the age range of 18 to 65 years;
3. Patients with diseases unsuitbale for the trial: history of allergies, severe cardiopulmonary disease, coagulation dysfunction, Alzheimer's disease, cerebral atrophy, acute phase or sequelae of cerebrovascular disease, cognitive impairment;
4. Patients in the acute phase of local or systemic bacterial infections;
5. Patients who cannot cooperate with the operation and evaluate the effect;
6. Other conditions that are considered inappropriate by the investigator to participate in the study.

Where it's running

  • Nanjing First Hospital
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.